or
Bookmark and Share
Method for inducing regeneration of injured nerve fibers
   
Document Number
US Patent 4966144
Issued Date
October 30, 1990
Link
Inventors
Map
Abstract
Light irradiation having a wavelength of 380-1200 nm was found to have beneficial healing properties on the nervous system. By the method, the regeneration of an injured spinal cord is induced by transplanting a nerve graft into an injured site of the spinal cord and post-operatively irradiating with light having the above specified wavelength.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
15
Comments:
no comments yet
Owner
Published
October 30, 1990
Application Number
07/204,207
Filed
June 8, 1988
US Classification
607/89  
Int'l Classification
A61N   5/06   (20060101)  
Assistant Examiner
Attorney/Law Firm
Priority Data
Jun 09, 1987 [IL] 82830
USPTO Field of Search
128/345   128/346   128/347   128/348   128/349   128/350   128/351   128/352   128/353   128/354   128/355   128/356   128/357   128/358   128/359   128/360   128/361   128/362   128/363   128/364   128/365   128/366   128/367   128/368   128/369   128/370   128/371   128/372   128/373   128/374   128/375   128/376   128/377   128/378   128/379   128/380   128/381   128/382   128/383   128/384   128/385   128/386   128/387   128/388   128/389   128/390   128/391   128/392   128/393   128/394   128/395   128/396   128/397   128/398   128/303.1  
Related Patents
6479053 - Laser inactivation of inhibitory molecules in central nervous system myelin - Owned by President and Fellows of Harvard College

Methods for specifically inactivating myelin proteins which inhibit nerve regeneration are described. These methods are useful to promote axon regeneration.

5580555 - Regeneration of injured central nervous system axons - Owned by Yeda Research and Development Co. Ltd. (Rehovot,IL)

Administration of tumor necrosis factor to the site of injured central nervous system axons will result in facilitation of the regeneration of axons across the site of the injury. Recombinant human tumor necrosis factor is the preferred substance for such use.

6273905 - Method for treating spinal cord transection

A method for the treatment of spinal cord transection using low level laser therapy in combination with allogenic implants. In one embodiment, embyronal nerve cells are cultured in vitro and transplanted to a site of spinal cord transection. The site is surgically closed and LLLT applied to a treatment point on the skin adjacent the transection site. To apply LLLT, a therapist applies pressure adequate to blanch the skin at the treatment point, and applies laser energy having a wavelength of about 630 nm to about 904 nm, with laser apparatus having a mean power output of about 100 mW to about 500 mW, at a dosage of about 1 joule/point, up to and including about 30 joules/point. Treatment times, total dosage, and number of treatment points are determined by the therapist or clinician trained in LLLT.

6808530 - Medical device for treatment of a gap or defect in the central nerve system - Owned by Karolinska Innovations AB (Stockholm,SE)

A medical device (1) of a biocompatible material for use in the treatment of a gap or defect in the central nervous system, which device has a proximal end (5) and a distal end (6) comprising openings (7). The device is adapted to enable connection of nerve fibers of gray and white matter between the proximal end (5) and distal end (6) thereof in predetermined openings (7). The device is of a substantially cylindrical form, or a substantially flat or plate like form and is made of plastic. The openings (7) in at least one end (5, 6) bear distinctively different indicia thereby to indicate whether nerve fibers of gray matter or nerve fibers of white matter are to be inserted therein.

5445146 - Biological tissue stimulation by low level optical energy

Biological tissue of a living subject is irradiated with optical energy at a wavelength and at a power dissipation level to cause the amount of optical energy absorbed and converted to heat in the tissue to be within a range bounded by a minimum absorption rate sufficient to elevate the average temperature of the irradiated tissue to a level above the basal body temperature, but which is less than the absorption rate at which tissue is converted into a collagenous substance. According to this method, a therapeutic, warming effect is produced within the irradiated tissue, but without causing tissue damage by thermal overheating. The method of using a low level reactive laser system from 100 milliwatts to 800 milliwatts in either a pulsed or continuous mode with optical energy produced by a Nd:YAG laser at a fundamental wavelength of 1064 nanometers has been found to reduce pain in soft tissues, reduce inflammation and enhance the healing of tissue by stimulation of microcirculation without subjecting the living tissue to damaging thermal effects. The energy density of the irradiated tissue is limited to the range of from about 1 joule per square centimeter to about 15 joules per square centimeter.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us